IAS 2021: Berlin Hosts 11th Conference on HIV Science

The world’s most influential meeting on HIV research has commenced in Germany with stakeholders converging virtually to deliberate more on new ways in HIV sciences. The conference is expected to come to an end on July 21, 2021 with

The 11th International AIDS Society (IAS 2021) Conference on HIV Science will feature discussions and research on the development of new long-acting anti-retroviral including lenacapavir, it will also investigate how people would like to receive their HIV care, including injectables; discuss new oral therapies for TB, treatment issues for children and more.

Fighting HIV

German-Chancellor, Angela Merkel spoke at the opening of the Conference on Sunday and said that HIV and other infectious diseases can only be fought with worldwide cooperation.

Lack of global cooperation

In her address, the IAS President and IAS 2021 Conference Co-chair, Dr Adeeba Kamarulzaman sadly observed that the lack of global cooperation in the fight against HIV/AIDS has made the pandemic linger unresolved for 40 years.

She said that if the energy put in the fight against the Covid-19 pandemic is put into stopping the spread of HIV, the disease would have reduced drastically over the years.

Lack of political will to fight HIV

The IAS 2021 Conference Co-chair, Hendrik Streeck noted that the political will and International cooperation put into combating the Covid-19 pandemic, scientists have been able to come up with eight licensed vaccines and over 30 clinical trials in phase III but stated that this is not the case with HIV/AIDS which is into its fourth decade.

“In the year we are celebrating the tragic anniversary of the first diagnosed cases of HIV and AIDS, only eight HIV vaccines have entered phase III, even though we are 40 years into the pandemic” He stated

IAS 2021 Conference on HIV Science

The IAS 2021 Conference on HIV Science is a biennial conference and the world’s most influential meeting on HIV research.

According to the IAS 2021 Website, the 2021 biennial conference will present the critical advances in basic, clinical and operational research that moves science into policy and practice.

” Through its open and inclusive programme development, the meeting sets the gold standard of HIV research featuring highly diverse and cutting-edge studies.

” IAS 2021 participants can expect a full conference experience via an easy-to-use digital platform that connects researchers, health care providers, advocates and policymakers,” the IAS 2021 website stated.